Drug therapies for tardive dyskinesia

Journal of Psychosocial Nursing and Mental Health Services

Volumn 49, Issue 6, 2011, Pages 13-16

  Robert, Howland ^a  

^a UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 79959584688     PISSN: 02793695     EISSN: None     Source Type: Journal    
DOI: 10.3928/02793695-20110510-01     Document Type: Article

References (17)

1. Bai, Y.M., Yu, S.C., & Lin, C.C. (2003). Risperidone for severe tardive dyskinesia: A 12-week randomized, double-blind, placebo-controlled study. Journal of Clinical Psychiatry, 64, 1342-1348.
2. Blum, I., Nisipeanu, P.F., & Roberts, E. (1987). Naloxone in tardive dyskinesia. Psychopharmacology, 93, 538.
3. Caroff, S.N., Walker, P., Campbell, C., Lorry, A., Petro, C., Lynch, K., & Gallop, R. (2007). Treatment of tardive dyskinesia with galantamine: A randomized controlled crossover trial. Journal of Clinical Psychiatry, 68, 410-415.
4. Chan, H.Y., Chiang, S.C., Chang, C.J., Gau, S.S., Chen, J.J., Chen, C.H.,... Lai, M.S. (2010). A randomized controlled trial of risperidone and olanzapine for schizophrenic patients with neuroleptic-induced tardive dyskinesia. Journal of Clinical Psychiatry, 71, 1226-1233.
5. Emsley, R., Turner, H.J., Schronen, J., Botha, K., Smit, R., & Oosthuizen, P.P. (2004). A single-blind randomized trial comparing quetiapine and haloperidol in the treatment of tardive dyskinesia. Journal of Clinical Psychiatry, 65, 696-701.
6. Goff, D.C., Renshaw, P.F., Sarid-Segal, O., Dreyfuss, D.A., Amico, E.T., & Ciraulo, D.A. (1993). A placebo-controlled trial of selegiline (L-deprenyl) in the treatment of tardive dyskinesia. Biological Psychiatry, 33, 700-706.
7. Huang, C.C., Wang, R.I., Hasegawa, A., & Alverno, L. (1981). Reserpine and alpha-methyldopa in the treatment of tardive dyskinesia. Psychopharmacology, 73, 359-362.
8. Kinon, B.J., Jeste, D.V., Kolkack-Walker, S., Stauffer, V., & Liu-Seifert, H. (2004). Olanzapine treatment for tardive dyskinesia in schizophrenia patients: A prospective clinical trial with patients randomized to blinded dose reduction. Progress in Neuropsychopharmacology and Biological Psychiatry, 28, 985-986.
9. Lieberman, J.A., Alvir, J., Mukherjee, S., & Kane, J.M. (1989). Treatment of tardive dyskinesia with bromocriptine: A test of the receptor modification strategy. Archives of General Psychiatry, 46, 908-913.
10. Lindenmayer, J.P., Gardner, E., Goldberg, E., Opler, L.A., Kay, S.R., van Praag, H.M.,... Zukin, S. (1988). High-dose naloxone in tardive dyskinesia. Psychiatry Research, 26, 19-28.
11. Moss, L.E., Neppe, V.M., & Drevets, W.C. (1993). Buspirone in the treatment of tardive dyskinesia. Journal of Clinical Psychopharmacology, 13, 204-209.
12. Ogunmefun, A., Hasnain, M., Alam, A., Osuala, T., & Regenold, W.T. (2009). Effect of donepezil on tardive dyskinesia. Journal of Clinical Psychopharmacology, 29, 102-104.
13. Ondo, W.G., Hanna, P.A., & Jankovic, J. (1999). Tetrabenazine treatment for tardive dyskinesia: Assessment by randomized videotape protocol. American Journal of Psychiatry, 156, 1279-1281.
14. Pappa, S., Tsouli, S., Apostolou, G., Mavreas, V., & Konitsiotis, S. (2010). Effects of amantadine on tardive dyskinesia: A randomized double-blind placebo-controlled study. Clinical Neuropharmacology, 33, 271-275.
15. Ross, C.A. (1987). Buspirone in the treatment of tardive dyskinesia. Medical Hypotheses, 22, 321-328.
16. Tammenmaa, I.A., Sailas, E., McGrath, J.J., Soares-Weiser, K., & Wahlbeck, K. (2004). Systematic review of cholinergic drugs for neuroleptic-induced tardive dyskinesia: A meta-analysis of randomized controlled trials. Progress in Neuropsychopharmacology and Biological Psychiatry, 28, 1099-1107.
17. Tamminga, C.A., Thaker, G.K., Moran, M., Kakigi, T., & Gao, X.M. (1994). Clozapine in tardive dyskinesia: Observations from human and animal model studies. Journal of Clinical Psychiatry, 55(Suppl. B), 102-106.